Evaluation of invitro antifungal activity of selected fungal species tested against opportunistic human pathogen Candida albicans release_qx6aqzkmtjg6xofuz5c4j3774e

by Aakriti Shukla, Apoorva Pathak

Published in Indian Journal of Pharmaceutical and Biological Research by IJPBR.

2020   Issue 01, p01-08

Abstract

Candida albicans is currently the fourth-leading cause of hospital-acquired bloodstream infections, reaching a mortality rate up to 35–40% for systemic or disseminated infections. Systemic mycoses can occur in patients with severely impaired immune systems (AIDS), with organ or bone marrow transplants, cancer patients undergoing chemotherapy and patients in ICU (neonates and elderly). It is therefore, obvious that there is substantial need for fast effective antifungal antibiotics to combat fungal infections. The present investigation has been proposed to screen effective fungal metabolites for the control of Candida albicans by evaluating the potential of fungal bioactive compounds, its purification and characterization.
In application/xml+jats format

Archived Files and Locations

application/pdf   1.7 MB
file_q4anebylefbpbbsxj7lenmyvou
ijpbr.in (web)
web.archive.org (webarchive)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Date   2020-03-27
Journal Metadata
Not in DOAJ
Not in Keepers Registry
ISSN-L:  2320-9267
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: 260075dd-fcb8-4170-9c4e-f56b9a644d96
API URL: JSON